- Home
- ATRC vs BSTZ Comparison
ATRC vs BSTZ Comparison
Compare ATRC & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- BSTZ
- Stock Information
- Founded
- ATRC 2000
- BSTZ 2019
- Country
- ATRC United States
- BSTZ United States
- Employees
- ATRC N/A
- BSTZ N/A
- Industry
- ATRC Medical/Dental Instruments
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- ATRC Health Care
- BSTZ Finance
- Exchange
- ATRC Nasdaq
- BSTZ Nasdaq
- Market Cap
- ATRC 1.6B
- BSTZ 1.6B
- IPO Year
- ATRC 2005
- BSTZ N/A
- Fundamental
- Price
- ATRC $34.13
- BSTZ $18.21
- Analyst Decision
- ATRC Strong Buy
- BSTZ
- Analyst Count
- ATRC 10
- BSTZ 0
- Target Price
- ATRC $48.50
- BSTZ N/A
- AVG Volume (30 Days)
- ATRC 627.8K
- BSTZ 303.2K
- Earning Date
- ATRC 04-30-2025
- BSTZ 01-01-0001
- Dividend Yield
- ATRC N/A
- BSTZ 8.31%
- EPS Growth
- ATRC N/A
- BSTZ N/A
- EPS
- ATRC N/A
- BSTZ 0.71
- Revenue
- ATRC $465,307,000.00
- BSTZ N/A
- Revenue This Year
- ATRC $14.60
- BSTZ N/A
- Revenue Next Year
- ATRC $12.58
- BSTZ N/A
- P/E Ratio
- ATRC N/A
- BSTZ $26.69
- Revenue Growth
- ATRC 16.55
- BSTZ N/A
- 52 Week Low
- ATRC $18.94
- BSTZ $14.11
- 52 Week High
- ATRC $43.11
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- ATRC 46.55
- BSTZ 38.84
- Support Level
- ATRC $31.02
- BSTZ $17.63
- Resistance Level
- ATRC $35.63
- BSTZ $19.35
- Average True Range (ATR)
- ATRC 1.71
- BSTZ 0.35
- MACD
- ATRC 0.08
- BSTZ 0.02
- Stochastic Oscillator
- ATRC 67.46
- BSTZ 33.66
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.